Becoming a leading pharma company in the new normal
The pharma supply chain has been stress tested to breaking point in the past few months. Many life science companies have transitioned to entirely...
COVID-19: A Catalyst for Change in Government-Industry Partnership
How outsourced pharma healthcare workers are supporting the Office for National Statistics COVID-19 Infection Survey as part of a Government-industry partnership. COVID-19 has seen the...
Crisis or crossroads? Key account management post-COVID
Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
From HIV to COVID-19: Charting the path of patient power
Patient power has evolved considerably since it was born to represent the voiceless during the 1980s HIV/AIDS crisis. Will COVID-19 provide the movement with...
The ABPI Code & Virtual Promotional Meetings
As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
Complex and challenging: Unlocking motor neurone disease
Motor neurone disease is a complex condition making the search for treatments a challenge, but work is ongoing to improve people’s lives. Motor neurone disease...
Getting focused on your local integrated care system
It’s essential that pharma professionals have a detailed understanding of their local Integrated Care System (ICS) to best focus their time in the new...
It’s all in the mind(set): digital transformation in pharma
The importance of mindset and company culture to enable digital transformation in pharma. Top 5 Takeaways Start with defining and understanding the traditional roadblocks of...
Reputation control: changing perceptions of pharma
Amanda Barrel investigates pharma’s reputation, self-regulation, compliance and how pharma can change perceptions of the work it does. Top 5 Takeaways
1 Only 57% of people...
What’s the point…of difference? Partnership working pharma and the NHS
Barriers to partnership working are breaking, it’s time for pharma to build on its differences to be more than a supplier. James Roach and...
Latest articles
GSK receives CHMP positive opinion for Zejula▼(niraparib)
GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
WAYLIVRA▼® (volanesorsen) for FCS to be available on the NHS in England
The National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for WAYLIVRA▼® (volanesorsen), the first and only therapy for adults...
AI-driven chemistry retrosynthesis tool to advance drug discovery
In a bid to help to bring drugs to market for patients most in need, Elsevier, a global research publishing and information analytics provider,...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
GSK receives CHMP positive opinion for Zejula▼(niraparib)
GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Rapid COVID-19 diagnostic test to be deployed in hospitals
A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Healthcare service providers Star Medical and OUTiCO merge to create new brand identity
Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry and part of the global Uniphar Group, has launched...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...